Chairperson(s) : Myung Ho Jeong (Gwangju Veterans Hospital, Republic of Korea)
Chairperson(s) : Hyeong Kyu Park (Soonchunhyang University, Republic of Korea), Han-Mo Yang (Seoul National University, Republic of Korea)
-
[OP3-1] Residual risk of remnant cholesterol in patients treated to LDL-C goal: a landmark analysis of the RACING trial
Sungyeon Park Yonsei University Wonju College of Medicine, Republic of Korea 08:50~09:00 -
[OP3-2] Lower cardiovascular event risk with bempedoic acid versus ezetimibe in statin-intolerant atherosclerotic cardiovascular disease (ASCVD): a 3,540-patient TriNetX analysis
Ahmed Elaraby Faculty of medicine, Al-Azhar University, Egypt 09:00~09:10 -
[OP3-3] Age-dependent association of atherogenic dyslipidemia with incident cardiovascular disease: a nationwide Korean cohort study
Ye Seul Yang Seoul National University College of Medicine, Republic of Korea 09:10~09:20 -
[OP3-4] Deep learning analysis of BMI, metabolic risk factors, and sex hormones in U.S. women: a NHANES study
Saheed Oladele Amusat Beaumont Hospital, Ireland 09:20~09:30 -
[OP3-5] Prevalence of high inflammatory risk in atherosclerotic cardiovascular disease with and without chronic kidney disease: findings from POSEIDON - a global cross-sectional prevalence study
Kyungsoo Won Novo Nordisk Korea, Republic of Korea 09:30~09:40 -
[OP3-6] Real-world efficacy and tolerability of inclisiran in Malaysian patients with atherosclerotic cardiovascular disease: a single-centre experience
Kim Fong Ng KPJ Kluang Specialist Hospital, Malaysia 09:40~09:50 -
[OP3-7] A Korean multidimensional social determinants of health index identifies individuals at elevated risk of severe coronary artery calcification: evidence from the CMERC cohort
Jooeun Jeon Ewha Womans University Mokdong Hospital, Republic of Korea 09:50~10:00 -
[OP3-8] Efficacy and safety of enlicitide decanoate, an oral macrocyclic peptide inhibitor of PCSK9, compared with bempedoic acid, ezetimibe, or bempedoic acid co-administered with ezetimibe in statin-treated adults with hypercholesterolemia: phase 3 CORALreef AddOn trial
Maria Carolina Emilia Villanueva MSD Philippines, Republic of Korea 10:00~10:10
Chairperson(s) : Sang-Hyun Kim (Seoul National University, Republic of Korea)
Chairperson(s) : Ick Mo Chung (Ewha Womans University, Republic of Korea)
Chairperson(s) : Sang Hong Baek (The Catholic University of Korea, Republic of Korea)
Chairperson(s) : Kwang-il Kim (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)
Panel(s) : Eu Jeong Ku (Seoul National University, Republic of Korea), Hyo-Suk Ahn (The Catholic University of Korea, Republic of Korea), Han-Mo Yang (Seoul National University, Republic of Korea)
-
Residual cardiovascular risk in hypertension despite optimal blood pressure control
Hyue Mee Kim Chung-Ang University, Republic of Korea 13:00~13:15 -
Lipid management in hypertensive patients
Jaehoon Chung Gachon University, Republic of Korea 13:15~13:30 -
Obesity, insulin resistance, and hypertension-related vascular injury
Mihye Seo Soonchunhyang University, Republic of Korea 13:30~13:45 - Panel Discussion 13:45~14:00
Chairperson(s) : Yong-Jae Kim (Kim's Neurology Clinic, Republic of Korea), Sung Kee Ryu (Ewha Womans University, Republic of Korea)
Panel(s) : Jaeseok Kim (Yonsei University, Republic of Korea), Min Kyung Lee (Hanyang University, Republic of Korea), Min-Ho Lee (Sahmyook Medical Center, Republic of Korea)
-
Cardiologist perspective: implementing novel cardiometabolic therapies in CVD
Donna Shu-Han Lin Shin Kong Wu Ho-Su Memorial Hospital, Taiwan 14:10~14:30 -
Nephrologist’s perspective: kidney protection strategies to improve cardio-kidney outcomes
Jong Hyun Jhee Yonsei University, Republic of Korea 14:30~14:50 -
Endocrinologist perspective: optimizing combination therapy in complex CKM patients
Jae-Seung Yun The Catholic University of Korea, Republic of Korea 14:50~15:10 - Panel Discussion 15:10~15:40
Chairperson(s) : Yang Ha Kim (Ewha Womans University, Republic of Korea), Min-Jeong Shin (Korea University, Republic of Korea)
Panel(s) : Mogan Gim (Hankuk University of Foreign Studies, Republic of Korea), Jeong-Min Kim (Seoul National University, Republic of Korea), Seung-Hwan Lee (The Catholic University of Korea, Republic of Korea)
-
Dietary and social determinants of the human microbiome: implications for metabolic health
Soyoung Kwak Kyungpook National University, Republic of Korea 15:40~16:00 -
Understanding gene-diet interactions in cardiometabolic health: genetic risk scores and their modification by diet in Korean and UK biobank cohorts
Sunmin Park Hoseo University, Republic of Korea 16:00~16:20 -
Interaction effects of genetic variants and dietary intake on the development of metabolic syndrome
Dayeon Shin Ewha Womans University, Republic of Korea 16:20~16:40 - Panel Discussion 16:40~17:10
